Mind Body Intervention for Long COVID
The goal of this study is to determine if a mind-body intervention can help people suffering from symptoms associated with Long COVID. The study is a randomized trial examining the effectiveness of a mind body intervention in reducing somatic symptoms from Long COVID in participants as compared to usual care and an active control (second mind body intervention). The investigators will secondarily investigate whether the intervention alleviates individual somatic complaints and improves daily functioning, relative to usual care and the active control
• Adult (≥ 18 years of age)
• Infection with Sars-COV2 (i. e., positive antibody, antigen, or PCR testing)
• Symptoms attributed only to COVID-19 and not to known comorbid disease (e.g., other infections, cancer, etc)
• A somatic symptom score ≥ 10 on the SSS-8 questionnaire with involvement of at least 3 domains
• Symptoms present at least 3 day a week for a minimum of 3 months
• Willingness to engage in a Mind-Body intervention